News Oligomerix Awarded 1.98 Million NIH SBIR-Phase IIb Grant October 17, 2018 By vera This article is sourced from an external publication. Read the original → ← PreviousOligomerix to Participate in the NIH Innovation Zone at 2019 BIO International ConventionNext →Oligomerix Relocates to Albert Einstein College of Medicine Campus
